| PERIOD ENDING | 27-Mar-09 | 26-Dec-08 | 26-Sep-08 | 27-Jun-08 | | Total Revenue | 2,247,000 | 2,674,000 | 2,961,000 | 2,907,000 | | Cost of Revenue | 1,024,000 | 2,083,000 | 1,895,000 | 2,356,000 | | | Gross Profit | 1,223,000 | 591,000 | 1,066,000 | 551,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 477,000 | (329,000) | 106,000 | (395,000) | | Non Recurring |
-
|
-
|
-
| 2,000 | | Others | 224,000 | 228,000 | 227,000 | 227,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 522,000 | 692,000 | 733,000 | 717,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (9,000) | (172,000) | 8,000 | 6,000 | | Earnings Before Interest And Taxes | 513,000 | 520,000 | 741,000 | 723,000 | | Interest Expense | 141,000 | 136,000 | 131,000 | 133,000 | | Income Before Tax | 372,000 | 384,000 | 610,000 | 590,000 | | Income Tax Expense | 126,000 | 137,000 | 228,000 | 205,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 246,000 | 247,000 | 382,000 | 385,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 246,000 | 247,000 | 382,000 | 385,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $246,000 | $247,000 | $382,000 | $385,000 |
|
0.45% Nasdaq 
0.20%
Income Statement
